Global CAR-T Cell Therapy Market: Industry Analysis and Forecast (2020-2026) by Target Antigen, Therapeutic Application, End-Users and Region

Global CAR-T Cell Therapy Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 34% during forecast period.

Global CAR-T Cell Therapy Market Overview:

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack cancer.

Global CAR-T Cell Therapy Market Dynamics:

Rising prevalence of cancer coupled with high demand for effective treatment to cure cancer is driving the market growth.

Recent studies suggest that over 1.7 million new cancer patients are recorded in the U.S. alone and nearly 4.3 million in China. A rising number of adults and children developing cancer is expected to lead to high demand for an effective and reliable therapeutic treatment approach for the improvement of the quality of patient’s lives. Moreover, the development of new and effective therapy options to cure symptoms of the disease is also a vital factor contributing to the growth of the CAR-T cell therapy market. Increasing government initiatives for improving health care infrastructure and promoting research for cell therapy in cancer is fuelling the growth of the market. In December 2016, the National Cancer Advisory Board authorized US$ 1.8 Bn in funding for Cancer Moonshot, which is an initiative taken up to accelerate research with an aim to make more therapies available to patients with cancer. However, High costs associated with CAR-T therapy and lack of cost-effective therapies for cancer have influenced the health conditions of the population and have led to a low average life expectancy. These factors may hinder the market growth. The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global CAR-T Cell Therapy Market Segment Analysis:

The global CAR-T Cell Therapy market is segmented on the basis of Target Antigen, Therapeutic Application and End-Users.

Based on Target Antigen, CD19/CD22 target antigens are estimated to hold the largest market share. The strong growth is creditable to the high approval rate of the antigens and their commercialization since 2017. On the other hand, BCMA (B-cell maturation antigen) segment is anticipated to record a robust growth rate growth over the forecasted years. Global CAR-T Cell Therapy Market To know about the Research Methodology :- Request Free Sample Report Based on Therapeutic Application, diffuse large B-cell lymphoma is expected to dominate the global market. It accounted for 56.1% of the total market share in 2019. The Multiple Myeloma (MM) segment is expected to register a significant growth rate over the forecast period.

Global CAR-T Cell Therapy Market Regional Insights:

Global CAR-T Cell Therapy Market 1

North America is expected to dominate global market over forecast years.

North America’s market growth is attributed due to the rapid development and launch of new therapies for the treatment of cancer by key players in the market. For instance, in August 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah, a CAR-T cell therapy to treat pediatric and young adult patients suffering from a form of acute lymphoblastic leukemia. Moreover, a large patient pool suffering from cancer in the U.S. and Canada is expected to further fuel the growth of the region in the global market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2016, around 171,000 patients with blood cancer are diagnosed each year in the U.S. Europe is expected to hold the second-largest market during the forecast period.

Asia Pacific is expected to witness lucrative growth during forecast period.

The Asia Pacific is expected to exhibit the highest growth over the forecast period, owing to the increasing number of global players collaborating and signing research as well as manufacturing contracts for CAR-T cell therapies with local players in the region. For instance, Cesca Therapeutics signed a license agreement with China-based, Boyalife Group, in March 2018, for CAR-T cell-related bioprocessing, development, and manufacturing outsourcing. The report also helps in understanding Global CAR-T Cell Therapy Market dynamics, structure by analyzing the market segments and project the Global CAR-T Cell Therapy Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global CAR-T Cell Therapy Market make the report investor’s guide.

Global CAR-T Cell Therapy Market, Key developments:

• In February 2021, the U.S. FDA granted approval of Breyanzi (lisocabtagene maraleucel) to Juno Therapeutics, a Bristol-Myers Squibb company. Breyanzi is approved for the treatment of adults with relapsed or refractory large-B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment. • In July 2020, the U.S. FDA approved the third CAR-T cell therapy, approving Kite Pharma’s brexucabtagene autoleucel, sold as Tecartus. It is the first CAR-T therapeutic to treat relapsed or refractory mantle cell lymphoma (MCL). The approval of these early CAR-T cell therapies has opened the gates for many other types of cell and gene therapies to claim respect, from regulators, as well as the scientific and medical community at large.

Global CAR-T Cell Therapy Market Scope: Inquire before buying

Global CAR-T Cell Therapy Market 2

Global CAR-T Cell Therapy Market, by Region:

• North America • Europe • South America • MEA • APAC

Global CAR-T Cell Therapy Market, Key players:

• Gilead Sciences • Novartis AG • Gracell Biotechnology Ltd • Aeon Therapeutics • CARsgen Therapeutics • Daiichi Sankyo • Celegne • Otsuka Pharmaceutical • Biocon • Ono Pharmaceutical • Japan Tissue Engineering • Nipro Corporation • Takeda Pharmaceutical Company • Astellas Pharma • PersonGen Biomedicine • Hebei Senlang Biotech • Eli Lilly and Company • Johnson & Johnson Private Limited
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global CAR-T Cell Therapy Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the CAR-T Cell Therapy Market 3.4. Geographical Snapshot of the CAR-T Cell Therapy Market, By Manufacturer share 4. Global CAR-T Cell Therapy Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global CAR-T Cell Therapy Market 5. Supply Side and Demand Side Indicators 6. Global CAR-T Cell Therapy Market Analysis and Forecast, 2019-2026 6.1. Global CAR-T Cell Therapy Market Size & Y-o-Y Growth Analysis. 7. Global CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 7.1.1. CD 19/ CD 22 7.1.2. HER 1 7.1.3. BCMA 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 7.2.1. Acute Lymphocytic Leukemia 7.2.2. Diffuse large B-cell lymphoma 7.2.3. Chronic Lymphocytic Leukemia 7.2.4. Hepatocellular Carcinoma 7.2.5. Others 7.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 7.3.1. Hospitals 7.3.2. Cancer Research Institutes 7.3.3. Clinics & Ambulatory Centers 8. Global CAR-T Cell Therapy Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 9.1.1. CD 19/ CD 22 9.1.2. HER 1 9.1.3. BCMA 9.1.4. Others 9.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 9.2.1. Acute Lymphocytic Leukemia 9.2.2. Diffuse large B-cell lymphoma 9.2.3. Chronic Lymphocytic Leukemia 9.2.4. Hepatocellular Carcinoma 9.2.5. Others 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 9.3.1. Hospitals 9.3.2. Cancer Research Institutes 9.3.3. Clinics & Ambulatory Centers 10. North America CAR-T Cell Therapy Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 12. Canada CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 13. Mexico CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 14. Europe CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 15. Europe CAR-T Cell Therapy Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 17. France CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 18. Germany CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 19. Italy CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 20. Spain CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 21. Sweden CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 22. CIS Countries CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 23. Rest of Europe CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 24. Asia Pacific CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 25. Asia Pacific CAR-T Cell Therapy Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 27. India CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 28. Japan CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 29. South Korea CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 30. Australia CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 31. ASEAN CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 32. Rest of Asia Pacific CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 33. Middle East Africa CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 34. Middle East Africa CAR-T Cell Therapy Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 36. GCC Countries CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 37. Egypt CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 38. Nigeria CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 39. Rest of ME&A CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 40. South America CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 41. South America CAR-T Cell Therapy Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 43. Argentina CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 44. Rest of South America CAR-T Cell Therapy Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global CAR-T Cell Therapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Gilead Sciences 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Novartis AG 45.3.3. Gracell Biotechnology Ltd 45.3.4. Aeon Therapeutics 45.3.5. CARsgen Therapeutics 45.3.6. Daiichi Sankyo 45.3.7. Celegne 45.3.8. Otsuka Pharmaceutical 45.3.9. Biocon 45.3.10. Ono Pharmaceutical 45.3.11. Japan Tissue Engineering 45.3.12. Nipro Corporation 45.3.13. Takeda Pharmaceutical Company 45.3.14. Astellas Pharma 45.3.15. PersonGen Biomedicine 45.3.16. Hebei Senlang Biotech 45.3.17. Eli Lilly and Company 45.3.18. Johnson & Johnson Private Limited 46. Primary Key Insights

About This Report

Report ID 98045
Category Healthcare
Published Date May 2021
Updated Date
Contact Us